Skip to Content

Join the 'Nuplazid' group to help and get support from people like you.

Nuplazid News

Psychiatric Drugs May Reduce Ex-Prisoners' Violent Crime Rate

Posted 2 Nov 2016 by Drugs.com

TUESDAY, Nov. 1, 2016 – Released prisoners may be less likely to commit violent crimes if they're prescribed certain kinds of psychiatric medications, a new study suggests. These medications can affect someone's mental state. They include antidepressants, antipsychotics, psychostimulants, drugs to treat addiction and antiepileptic drugs, the researchers said. The study authors looked at information on more than 22,000 prisoners in Sweden. They were released between July 2005 and December 2010. The researchers had a median of nearly five years of follow-up information. During that time, 18 percent of the prisoners committed violent crimes, the researchers said. Three classes of drugs were linked to much lower rates of violent crimes. Antipsychotics were tied to a 42 percent reduction in violent crimes. For psychostimulants, the reduction was 38 percent. Drugs to treat addiction were ... Read more

Related support groups: Depression, Anxiety, Anxiety and Stress, Lexapro, Zoloft, Wellbutrin, Prozac, Seroquel, Celexa, Citalopram, Major Depressive Disorder, Paxil, Abilify, Sertraline, Lithium, Bupropion, Amitriptyline, Viibryd, Fluoxetine, Schizophrenia

Antipsychotic Meds Pose Little Danger to Fetus, Study Finds

Posted 17 Aug 2016 by Drugs.com

WEDNESDAY, Aug. 17, 2016 – Taking antipsychotic medicines in early pregnancy does not significantly increase the risk of birth defects, a new study finds. "In general, the use of any medication should be avoided during pregnancy [if possible]," explained study co-author Krista Huybrechts of Brigham and Women's Hospital in Boston. "However, for women suffering from schizophrenia, bipolar disorder, or major depressive disorder, avoiding medication use is often impossible, given that there are very few alternative treatment options," she said in a hospital news release. But how safe is exposure to these drugs for the developing fetus? To find out, Huybrecht's team tracked Medicaid data on 1.3 million pregnant women in order to assess the effects of older (typical) antipsychotic drugs and newer (atypical) versions, which are less likely to affect fertility. The study focused on the most ... Read more

Related support groups: Birth Control, Depression, Contraception, Bipolar Disorder, Seroquel, Major Depressive Disorder, Abilify, Schizophrenia, Latuda, Zyprexa, Risperdal, Risperidone, Schizoaffective Disorder, Geodon, Saphris, Quetiapine, Seroquel XR, Olanzapine, Delivery, Invega

'Managing' Elderly Patients Without Powerful Antipsychotics

Posted 26 Jul 2016 by Drugs.com

MONDAY, July 25, 2016 – About 25 percent of dementia patients in U.S. nursing homes are still quieted with risky antipsychotic medications. Now, a small study suggests that managing these difficult patients, instead of medicating them, could obtain better results. "Drugs have a place, but should not be first-line treatments. They don't work well, and there are side effects," said study author Dr. Henry Brodaty, a professor of aging and mental health at the University of New South Wales in Sydney, Australia. Antipsychotic drugs such as Risperdal (risperidone), Abilify (aripiprazole) and Seroquel (quetiapine) are approved to treat serious psychiatric conditions such as bipolar disorder and schizophrenia. But in seniors, they're often used to calm aggressive or violent behavior linked to dementia. "They're basically a sedative," said Dean Hartley, director of science initiatives with the ... Read more

Related support groups: Bipolar Disorder, Seroquel, Abilify, Schizophrenia, Mania, Latuda, Dementia, Zyprexa, Risperdal, Risperidone, Schizoaffective Disorder, Geodon, Saphris, Quetiapine, Seroquel XR, Alzheimer's Disease, Olanzapine, Invega, Clozapine, Rexulti

Nuplazid Approved for Parkinson's Hallucinations

Posted 3 May 2016 by Drugs.com

MONDAY, May 2, 2016 – Nuplazid (pimavanserin) has been approved by the U.S. Food and Drug Administration to treat hallucinations and delusions associated with Parkinson's disease. As many as half of people with Parkinson's may have psychosis that lead to hallucinations and delusions, the agency said in a news release announcing the approval. This can lead to behaviors including difficulty associating with loved ones or the inability to take care of oneself. Some 50,000 Americans are diagnosed annually with Parkinson's, the FDA noted, and the total number of affected Americans is about 1 million. The neurological disorder typically affects people 60 and older, and is triggered when cells that are supposed to produce a brain chemical called dopamine become impaired or die. Dopamine helps transmit neurologic signals that lead to smooth, "purposeful" movement, the FDA said, during ... Read more

Related support groups: Parkinson's Disease, Psychosis, Nuplazid, Pimavanserin, Parkinson's Disease Psychosis

FDA Approves Nuplazid (pimavanserin) for Parkinson’s Disease Psychosis

Posted 3 May 2016 by Drugs.com

April 29, 2016 – The U.S. Food and Drug Administration today approved Nuplazid (pimavanserin) tablets, the first drug approved to treat hallucinations and delusions associated with psychosis experienced by some people with Parkinson’s disease. Hallucinations or delusions can occur in as many as 50 percent of patients with Parkinson’s disease at some time during the course of their illness. People who experience them see or hear things that are not there (hallucinations) and/or have false beliefs (delusions). The hallucinations and delusions experienced with Parkinson’s disease are serious symptoms, and can lead to thinking and emotions that are so impaired that the people experiencing them may not relate to loved ones well or take appropriate care of themselves. “Hallucinations and delusions can be profoundly disturbing and disabling,” said Mitchell Mathis, M.D., director of the Div ... Read more

Related support groups: Parkinson's Disease, Nuplazid, Pimavanserin

Ask a Question

Further Information

Related Condition Support Groups

Parkinson's Disease Psychosis

Nuplazid Patient Information at Drugs.com